Загрузка...
TIGIT in cancer immunotherapy
Tumors evade immune-mediated recognition through multiple mechanisms of immune escape. On chronic tumor antigen exposure, T cells become dysfunctional/exhausted and upregulate various checkpoint inhibitory receptors (IRs) that limit T cells’ survival and function. During the last decade, immunothera...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477968/ https://ncbi.nlm.nih.gov/pubmed/32900861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000957 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|